Barely Significant
← all excerpts

Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.

CNS Drugs · 2021 · PMC7873005 · PMID 33479851

Europe PMCDOI
1
hedged sentence
0.0915
closest p · 1.8× alpha
0.0915
boldest claim

The sentences

did not reach statistical significancep = 0.0915so close (0.05 < p ≤ 0.1)
On the other hand, the median percent reduction in monthly drop seizures for FFA0.2 did not reach statistical significance compared with placebo (13.2%; p = 0.0915).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.